āshibio is developing novel therapies for patients with rare bone and connective tissue disorders that have the potential to slow the progression of disease.
Investors 1
Date | Name | Website |
26.10.2023 | MPM Capita... | mpmcapital... |
Date | Name | Website |
26.10.2023 | MPM Capita... | mpmcapital... |